At the time of the Kentgrove announcement, I think the shares...

At the time of the Kentgrove announcement, I think the shares were trading at AU$0.007 cents per share.

Kentgrove agreed to acquire 100M shares for AU$1,350,000.  That means Kentgrove paid AU$0.0135 per share, a 93% premium to the then share price.  Why such a premium, that hasn't happened previously?

Let's hope we start seeing some nice announcements including an update on the new genetic risk predictive tests (i.e. Updated Breast Cancer Risk Test, Implementation of Colorectal Cancer Test, Prostate Cancer, Melanoma, Type 2 Diabetes, Cardiovascular Disease, etc), the China Joint Venture, benefits coming the recent U.S. / U.K. collaborations, etc.